Peter Browett, Zhenqiang Wu, Humphrey Pullon, Jenny Yoon, Melissa Firth, Shani Peleg, Emma-Jane McDonald, Sarah Benge, Bart Baker, Merit Hanna, Victoria Campion, Shahidul Islam, Gordon Royle, Nicky Lawrence, Katrina Sharples, Lucy Pemberton. "Is initial treatment with dasatinib for newly diagnosed chronic Phase chronic myeloid leukemia, followed by switching to imatinib for those that achieve MR3.0 at 12 months, an effective strategy? Results of the Phase 2 kinase inhibition with sprycel startup study." Blood, 2025. doi:10.1182/blood-2025-2006